Sort
34,240 grants matching “atherosclerosis”
Cardiovascular Engineering Science
$1,155,645University Of California San Diego · T32 · FY2005 · HL
Pre- and Peri-natal Predictors of Childhood Obesity
$1,154,534Matthew W Gillman · Harvard Pilgrim Health Care, Inc. · R37 · FY2015 · HD
GENE-DIET INTERACTIONS AND HEART DISEASE
$1,154,111Harvard University (Sch Of Public Hlth) · R01 · FY2002 · HL
Trial to Assess Chelation Therapy 2- TACT2 CCC
$1,153,749Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · UH3 · FY2021 · AT
RESEARCH CENTER FOR PHARMACOLOGY AND DRUG TOXICOLOGY
$1,153,281Vanderbilt University · P50 · FY2000 · GM
EARLY NATURAL HISTORY OF ARTERIOSCLEROSIS
$1,153,179Tulane University Of Louisiana · U01 · FY2000 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport
$1,152,596University Of Texas Hlth Sci Ctr Houston · R01 · FY2004 · HL
Atherosclerosis Risk in Communities Study (ARIC)
$1,152,347Johns Hopkins University · N01 · FY2008 · HL
Multimodal MRI biomarkers of small vessel disease for older persons with and without dementia.
$1,152,217Julie A Schneider · Rush University Medical Center · UH3 · FY2019 · NS
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD
$1,151,732Dariush Mozaffarian · Tufts University Boston · R01 · FY2018 · HL
PATHOBIOLOGY OF MACROVASCULAR DISEASE IN DIABETES
$1,151,182University Of Washington · P01 · FY2001 · DK
Oral Delivery Vehicles for RNAi Therapies
$1,150,827Michael P Czech · Univ Of Massachusetts Med Sch Worcester · R01 · FY2013 · DK
Clinical Center for Look AHEAD: Health in Diabetes
$1,149,442Baylor College Of Medicine · U01 · FY2001 · DK
The Role Of Nrf2 In Susceptibility To Hyperoxic Lung Injury
$1,149,200Steven R Kleeberger · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
24-hour Activity Cycles to Optimize Cognitive Resilience to Alzheimer's Disease in African Americans: The Jackson Heart Study
$1,149,017Kelley Pettee Gabriel · University Of Alabama At Birmingham · R01 · FY2020 · AG
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD
$1,147,817Dariush Mozaffarian · Tufts University Boston · R01 · FY2020 · HL
Neurocognitive Impairment Assessment in Symptomatic Carotid Occlusion Recanalized Endovascularly: NIA SCORE
$1,147,756David M. Hasan · Duke University · R01 · FY2022 · AG
Contribution of Longitudinal Neighborhood Determinants to Cognitive Health and Dementia Disparities within a Multi-Ethnic Cohort
$1,147,726Jana Ariel Hirsch · Drexel University · R01 · FY2021 · AG
Modeling DNA Diversity in Reverse Cholesterol Transport
$1,146,693Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2009 · HL
Modeling DNA Diversity in Reverse Cholesterol Transport
$1,146,614Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston · R01 · FY2011 · HL
Redox and other mechanistic insights into cancer and cardiovascular diseases
$1,145,873Paul M Hwang · National Heart, Lung, And Blood Institute · ZIA · FY2021 · HL
TMAO and Initiation, Extent, and Clinical Onset of Atherosclerotic CVD
$1,145,137Dariush Mozaffarian · Tufts University Boston · R01 · FY2019 · HL
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7
$1,144,448Steven Shea · Columbia University Health Sciences · N01 · FY2021 · HL
Trial to Assess Chelation Therapy 2- TACT2 CCC
$1,144,023Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · UH3 · FY2020 · AT
Molecular Correlates Of Human Ca2+ Channel Regulation
$1,143,539Nikolai Soldatov · National Institute On Aging · Z01 · FY2008 · AG